Skip to content

Our Products and Expertise

Commercial Pharmaceuticals

STERILE FOCUS BRANDS

REGIONAL BRANDS


Anaesthetics

Aspen has a comprehensive portfolio of 20 mature Anaesthetics Brands, having acquired two complementary Anaesthetics portfolios from AstraZeneca and GSK. Our diverse product range includes general anaesthetics, muscle relaxants as well as a number of local anaesthetics including topical agents, making Aspen a leading global supplier in the Anaesthetics category (House of Anesthesia), outside of the USA.


Thrombosis

Our Thrombosis portfolio is a global offering (excluding USA) which is comprised largely of a broad range of specialist injectable anticoagulants. In addition to the heparin based anticoagulant portfolio, Aspen also produces Arixtra, a Xa inhibitor with a wide range of indications, including VTE treatment and prophylaxis, deep vein thrombosis, pulmonary embolism and acute coronary syndrome treatment.

High Potency & Cytotoxics, Women's Health, and Pain Management

Our Regional Brands are geographically diverse and include products for High Potency & Cytotoxics, Women's Health and Pain Management. The products within this segment have strong brand equity and are actively promoted through our experienced regional marketing and sales teams.

 

 

Key Products
  • Diprivan
  • Marcaine
  • Naropin
  • Ultiva
  • Emla
  • Xylocaine
Key Products
  • Arixtra
  • Clodipan
  • Rivanex

 

 

Key Products
  • Eltroxin
  • Gracial
  • Imuran
  • Ovestin
  • Solpadeine
  • Zyloric

Commercial Pharmaceuticals

STERILE FOCUS BRANDS


Anaesthetics

Aspen has a comprehensive portfolio of 20 mature Anaesthetics Brands, having acquired two complementary Anaesthetics portfolios from AstraZeneca and GSK. Our diverse product range includes general anaesthetics, muscle relaxants as well as a number of local anaesthetics including topical agents, making Aspen a leading global supplier in the Anaesthetics category (House of Anesthesia), outside of the USA.

Key Products
  • Diprivan
  • Marcaine
  • Naropin
  • Ultiva
  • Emla
  • Xylocaine


Thrombosis

Our Thrombosis portfolio is a global offering (excluding USA) which is comprised largely of a broad range of specialist injectable anticoagulants. In addition to the heparin based anticoagulant portfolio, Aspen also produces Arixtra, a Xa inhibitor with a wide range of indications, including VTE treatment and prophylaxis, deep vein thrombosis, pulmonary embolism and acute coronary syndrome treatment.

Key Products
  • Arixtra
  • Clodipan
  • Rivanex

 

 

REGIONAL BRANDS

High Potency & Cytotoxics, Women's Health, and Pain Management

Our Regional Brands are geographically diverse and include products for High Potency & Cytotoxics, Women's Health and Pain Management. The products within this segment have strong brand equity and are actively promoted through our experienced regional marketing and sales teams.

Key Products
  • Eltroxin
  • Gracial
  • Imuran
  • Ovestin
  • Solpadeine
  • Zyloric
Scroll To Top